Royal London Asset Management Ltd. Boosts Stock Position in Revvity, Inc. (NYSE:RVTY)

Royal London Asset Management Ltd. lifted its stake in shares of Revvity, Inc. (NYSE:RVTY - Free Report) by 15.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 50,437 shares of the company's stock after buying an additional 6,770 shares during the quarter. Royal London Asset Management Ltd.'s holdings in Revvity were worth $5,629,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently modified their holdings of RVTY. Generali Investments Management Co LLC acquired a new stake in Revvity in the fourth quarter worth $385,000. Primecap Management Co. CA grew its stake in shares of Revvity by 2.0% in the 4th quarter. Primecap Management Co. CA now owns 951,885 shares of the company's stock valued at $106,240,000 after buying an additional 18,580 shares during the period. Tocqueville Asset Management L.P. increased its position in Revvity by 91.2% in the 4th quarter. Tocqueville Asset Management L.P. now owns 234,625 shares of the company's stock valued at $26,186,000 after buying an additional 111,937 shares in the last quarter. Signaturefd LLC raised its stake in Revvity by 6.8% during the 4th quarter. Signaturefd LLC now owns 1,668 shares of the company's stock worth $186,000 after buying an additional 106 shares during the period. Finally, Cibc World Markets Corp raised its stake in Revvity by 15.1% during the 4th quarter. Cibc World Markets Corp now owns 19,304 shares of the company's stock worth $2,155,000 after buying an additional 2,532 shares during the period. Institutional investors own 86.65% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. KeyCorp boosted their price objective on Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Bank of America upgraded shares of Revvity from a "neutral" rating to a "buy" rating and set a $138.00 price target for the company in a research note on Friday, December 13th. Raymond James reaffirmed an "outperform" rating and issued a $145.00 price objective (up from $140.00) on shares of Revvity in a research note on Monday, February 3rd. Sanford C. Bernstein downgraded shares of Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 target price for the company. in a research report on Friday, January 10th. Finally, Barclays raised their price target on shares of Revvity from $135.00 to $140.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Four research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $136.25.

Remove Ads

Revvity Stock Performance

Shares of RVTY stock traded up $0.05 during trading on Thursday, hitting $107.41. The company's stock had a trading volume of 614,018 shares, compared to its average volume of 850,115. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. The company has a market cap of $12.90 billion, a PE ratio of 48.60, a P/E/G ratio of 3.82 and a beta of 1.06. The business has a fifty day moving average of $115.66 and a 200-day moving average of $117.35. Revvity, Inc. has a 52 week low of $97.32 and a 52 week high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same period in the prior year, the firm posted $1.25 earnings per share. As a group, research analysts anticipate that Revvity, Inc. will post 4.94 earnings per share for the current year.

Revvity Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be issued a dividend of $0.07 per share. The ex-dividend date is Thursday, April 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.26%. Revvity's dividend payout ratio (DPR) is presently 12.67%.

Insiders Place Their Bets

In other Revvity news, insider Tajinder S. Vohra sold 5,492 shares of the firm's stock in a transaction on Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total value of $641,520.52. Following the completion of the sale, the insider now directly owns 19,652 shares of the company's stock, valued at $2,295,550.12. This trade represents a 21.84 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Joel S. Goldberg sold 15,170 shares of the company's stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total value of $1,922,494.10. Following the transaction, the insider now directly owns 33,400 shares in the company, valued at $4,232,782. This represents a 31.23 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.68% of the company's stock.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.